Squarepoint’s Outlook Therapeutics OTLK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $249K | Buy |
+155,624
| New | +$249K | ﹤0.01% | 2251 |
|
|
2024
Q3 | – | Sell |
-31,388
| Closed | -$232K | – | 2895 |
|
|
2024
Q2 | $232K | Buy |
+31,388
| New | +$232K | ﹤0.01% | 2084 |
|
|
2023
Q3 | – | Sell |
-15,829
| Closed | -$551K | – | 2740 |
|
|
2023
Q2 | $551K | Buy |
15,829
+12,572
| +386% | +$437K | ﹤0.01% | 1556 |
|
|
2023
Q1 | $71K | Buy |
+3,257
| New | +$71K | ﹤0.01% | 2075 |
|
|
2022
Q4 | – | Sell |
-1,605
| Closed | -$39K | – | 2539 |
|
|
2022
Q3 | $39K | Buy |
+1,605
| New | +$39K | ﹤0.01% | 1969 |
|
|
2022
Q2 | – | Sell |
-1,597
| Closed | -$57K | – | 2494 |
|
|
2022
Q1 | $57K | Buy |
+1,597
| New | +$57K | ﹤0.01% | 2097 |
|
|
2021
Q4 | – | Sell |
-565
| Closed | -$25K | – | 2743 |
|
|
2021
Q3 | $25K | Buy |
565
+5
| +0.9% | +$221 | ﹤0.01% | 2153 |
|
|
2021
Q2 | $28K | Sell |
560
-334
| -37% | -$16.7K | ﹤0.01% | 2536 |
|
|
2021
Q1 | $40K | Buy |
+894
| New | +$40K | ﹤0.01% | 2456 |
|
|
2020
Q3 | – | Sell |
-810
| Closed | -$21K | – | 2584 |
|
|
2020
Q2 | $21K | Buy |
+810
| New | +$21K | ﹤0.01% | 2078 |
|
|
2019
Q3 | – | Sell |
-1,385
| Closed | -$58K | – | 2474 |
|
|
2019
Q2 | $58K | Buy |
+1,385
| New | +$58K | ﹤0.01% | 2200 |
|